Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Non Operating Income (2019 - 2025)

Pulmonx has reported Non Operating Income over the past 7 years, most recently at $758000.0 for Q3 2025.

  • Quarterly Non Operating Income rose 477.11% to $758000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $886000.0 through Sep 2025, up 597.75% year-over-year, with the annual reading at $256000.0 for FY2024, 138.04% up from the prior year.
  • Non Operating Income was $758000.0 for Q3 2025 at Pulmonx, up from -$116000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $758000.0 in Q3 2025 and troughed at -$432000.0 in Q3 2022.
  • The 5-year median for Non Operating Income is -$106000.0 (2021), against an average of -$32722.2.
  • Year-over-year, Non Operating Income tumbled 277.61% in 2023 and then surged 477.11% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$383000.0 in 2021, then soared by 152.48% to $201000.0 in 2022, then tumbled by 277.61% to -$357000.0 in 2023, then skyrocketed by 121.57% to $77000.0 in 2024, then surged by 884.42% to $758000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non Operating Income are $758000.0 (Q3 2025), -$116000.0 (Q2 2025), and $167000.0 (Q1 2025).